Kexxtone is a prescription-only medicine (POM-V) and must be prescribed by a vet. Kexxtone is an intraruminal device containing monensin for the reduction of the incidence of ketosis in the peri-parturient dairy cow or heifer which is expected to develop ketosis.
- Continual release bolus containing monensin, providing 95 days coverage
- Reduces the incidence of ketosis in at-risk cows by up to 74%1
- Zero day withdrawal period for both meat and milk
Kexxtone is available as a box of 5 boluses
Kexxtone Product Information
Target activity of Kexxtone
Kexxtone is a prescription-only medicine (POM-V) and must be prescribed by a vet.
It is licensed for the reduction in the incidence of ketosis in the peri-parturient dairy cow or heifer which is expected to develop ketosis.
Hear why dairy farmers choose Kexxtone™
Hear feedback from other farmers about how Kexxtone™ has benefited their herd health and learn more about Ketosis:
Graham, Dairy Farmer, 530 Cows:
Andy, Dairy Farmer, 350 Cows:
Find out how Kexxtone could benefit your management of ketosis for optimal herd health: speak with your vet or with your Elanco Account Manager.
Identification of animals for treatment should be at veterinary discretion. Risk factors may include a history of energy-deficiency-related diseases, high body condition score and parity.
In the event of regurgitation, identify the animal by matching the animal ID number with the number on the intraruminal device and re-administer an undamaged intraruminal device.
Special precautions for use in animals
Hold treated cattle in a confined area for 1 hour after administration to observe for failure to swallow or regurgitation. If this occurs re-administer the intraruminal device if undamaged. If damaged, administer a new intraruminal device. Recheck cattle for up to 4 days after dosing to observe for signs of an intraruminal device lodging in the oesophagus. Signs of lodging may include bloat which may be followed by coughing, drooling, inappetence and unthriftiness.
Special precautions to be taken by the person administering Kexxtone
Exposure to the active substance may elicit an allergic response in susceptible individuals. People with known hypersensitivity to monensin or any of the excipients should avoid contact with Kexxtone.
Do not eat, drink or smoke when handling Kexxtone. Use gloves when handling, including during retrieval of a regurgitated intraruminal device. Remove gloves and wash hands and exposed skin after handling.
Ingestion or oral exposure to monensin can be fatal in dogs, horses, other equines or guinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary medicinal products containing monensin.
Due to the risk of bolus regurgitation, do not allow these species access to areas where treated cattle have been kept.
Keep dogs away from treated animals. Accidental ingestion of monensin by dogs has resulted in fatal consequences. In case of suspected ingestion by dogs, seek veterinary advice immediately.